SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-009405
Filing Date
2023-05-11
Accepted
2023-05-11 16:24:24
Documents
73
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rzlt-20230331x10q.htm   iXBRL 10-Q 1443895
2 EX-10.1 rzlt-20230331xex10d1.htm EX-10.1 137398
3 EX-10.2 rzlt-20230331xex10d2.htm EX-10.2 102830
4 EX-31.1 rzlt-20230331xex31d1.htm EX-31.1 15325
5 EX-32.1 rzlt-20230331xex32d1.htm EX-32.1 7364
  Complete submission text file 0001558370-23-009405.txt   7200001

Data Files

Seq Description Document Type Size
6 EX-101.SCH rzlt-20230331.xsd EX-101.SCH 53202
7 EX-101.CAL rzlt-20230331_cal.xml EX-101.CAL 45060
8 EX-101.DEF rzlt-20230331_def.xml EX-101.DEF 243776
9 EX-101.LAB rzlt-20230331_lab.xml EX-101.LAB 359130
10 EX-101.PRE rzlt-20230331_pre.xml EX-101.PRE 372407
67 EXTRACTED XBRL INSTANCE DOCUMENT rzlt-20230331x10q_htm.xml XML 1259266
Mailing Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065
Business Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065 650-206-4507
Rezolute, Inc. (Filer) CIK: 0001509261 (see all company filings)

IRS No.: 273440894 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39683 | Film No.: 23911425
SIC: 2834 Pharmaceutical Preparations